The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 and the unambiguous assignment of the C14 stereochemistry.

[reaction: see text] The first total synthesis of 15-deoxy-Delta12,14-prostaglandin J2 is reported. The highly unsaturated cyclopentenone prostaglandin was obtained via a silicon-tethered allenic [2 + 2 + 1] cycloaddition reaction developed in our group. In addition, the stereochemistry at C14 has been assigned unambiguously.

[1]  E. Nishizawa,et al.  Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogues. , 1983, Journal of medicinal chemistry.

[2]  T. Hoye,et al.  Reactions of pentacarbonyl(1-methoxyethylidene)molybdenum and -tungsten with α,ω-enynes : comparison with the chromium analogue and resulting mechanistic ramifications , 1992 .

[3]  C. Glass,et al.  Cyclopentenone prostaglandins: New insights on biological activities and cellular targets , 2001, Medicinal research reviews.

[4]  Jianliang Lu,et al.  A Short Synthesis of the Potent Antitumor Agent (±)-Hydroxymethylacylfulvene Using an Allenic Pauson-Khand Type Cycloaddition , 1999 .

[5]  J. Einhorn,et al.  Efficient and Highly Selective Oxidation of Primary Alcohols to Aldehydes by N-Chlorosuccinimide Mediated by Oxoammonium Salts. , 1996, The Journal of organic chemistry.

[6]  H. Wan,et al.  The allenic Pauson-Khand cycloaddition. Dependence in π-bond selectivity on substrate structure , 1998 .

[7]  G. Domínguez,et al.  Seven membered rings via intramolecular Pauson–Khand reactions , 2001 .

[8]  T. A. Ayers,et al.  Cyclizations of 3,4-pentadien-1-yllithium reagents , 1992 .

[9]  B. Pagenkopf,et al.  (Alkylthio)alkynes as Addends in the Co(0) Catalyzed Intramolecular Pauson-Khand Reaction. Substituent Driven Enhancements of Annulation Efficiency and Stereoselectivity , 2000 .

[10]  R. Aumann,et al.  Organische Synthesen mit übergangsmetallkomplexen, 19 ß‐Methylencyclopentenone durch templatgesteuerte [2 + 2 + 1]‐Cycloaddition von Alkinen an Allene und Kohlenmonoxid mit Eisencarbonyl , 1987 .

[11]  K. Sonogashira,et al.  A Convenient Synthesis of Ethynylarenes and Diethynylarenes , 1980 .

[12]  Y. Chung,et al.  Molybdenium mediated preparation of cyclopentenones , 1993 .

[13]  M. Ciufolini,et al.  PRACTICAL SYNTHESIS OF ()-CHLOROVULONE II , 1998 .

[14]  H. Wan,et al.  A new allenic Pauson-Khand cycloaddition for the preparation of α-methylene cyclopentenones , 1995 .

[15]  S. Buchwald,et al.  Scope of the Intramolecular Titanocene-Catalyzed Pauson−Khand Type Reaction1 , 1999 .

[16]  M. Tius,et al.  Cross-conjugated cyclopentenone prostaglandins synthesis of Δ7-10-chloro-15-deoxy PGA1 ethyl ester , 1998 .

[17]  H. Wan,et al.  An Intramolecular Allenic [2 + 2 + 1] Cycloaddition , 1998 .

[18]  R. Hsung,et al.  The first regioselective alpha-deprotonation and functionalization of allenamides. An application in intramolecular Pauson-Khand-type cycloadditions. , 2000, Organic letters.

[19]  K. Brummond,et al.  A silicon-tethered allenic Pauson–Khand reaction , 2002 .

[20]  M. Ahmar,et al.  Pauson-Khand cycloaddition of α,ω-allenynes , 1997 .

[21]  W. Wahli,et al.  Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... , 1995, Chemistry & biology.

[22]  F. Fitzpatrick,et al.  Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. , 1983, The Journal of biological chemistry.

[23]  B. Maryanoff,et al.  Trans stereoselectivity in the reaction of (4-carboxybutylidene)triphenylphosphorane with aromatic aldehydes , 1981 .

[24]  Yuichi Kobayashi,et al.  Synthesis of Δ7-prostaglandin A1 methyl ester , 2001 .

[25]  Yuji Koga,et al.  The rhodium-catalyzed Pauson–Khand reaction , 2001 .

[26]  Kay M. Brummond,et al.  A Rapid Synthesis of Hydroxymethylacylfulvene (HMAF) Using the Allenic Pauson−Khand Reaction. A Synthetic Approach to Either Enantiomer of This Illudane Structure , 2000 .

[27]  L. Hitchingham,et al.  The nature and composition of 15-deoxy-Delta(12,14)PGJ(2). , 2000, Prostaglandins & other lipid mediators.